Search Results - "Ludlam, H"

Invasive fungal infections: a review of epidemiology and management options by Enoch, D. A, Ludlam, H. A, Brown, N. M

“…Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK Correspondence D. A…”
Get full text

Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors by Hussain, Namath S, Piper, Mackenzie, Ludlam, W Grant, Ludlam, William H, Fuller, Cindy J, Mayberg, Marc R

“…Transient delayed postoperative hyponatremia (DPH) after transsphenoidal surgery (TSS) is common and can have potentially devastating consequences. However,…”
Get full text

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial by Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., Snyder, P., Tabarin, A., Biller, B. M. K., Findling, J., Melmed, S., Darby, C. H., Hu, K., Wang, Y., Freda, P. U., Grossman, A. B., Frohman, L. A., Bertherat, J.

“…Context: There is currently no medical therapy for Cushing’s disease that targets the pituitary adenoma. Availability of such a medical therapy would be a…”
Get full text

Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae by Swayne, R.L, Ludlam, H.A, Shet, V.G, Woodford, N, Curran, M.D

“…Abstract A real-time TaqMan multiplex polymerase chain reaction (PCR) assay was developed to detect genes encoding five types of serine carbapenemases (GES,…”
Get full text

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands by Fleseriu, Maria, Molitch, Mark, Dreval, Alexander, Biermasz, Nienke R, Gordon, Murray B, Crosby, Ross D, Ludlam, William H, Haviv, Asi, Gilgun-Sherki, Yossi, Mathias, Susan D

“…Medical treatment for acromegaly commonly involves receiving intramuscular or deep subcutaneous injections of somatostatin receptor ligands (SRLs) in most…”
Get full text

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice by Geer, Eliza B, Sisco, Jill, Adelman, Daphne T, Ludlam, William H, Haviv, Asi, Liu, Shuqian, Mathias, Susan D, Gelbaum, Dana, Shi, Lizheng

“…Acromegaly patients managed on Somatostatin receptor ligands (SRLs), the most common first-line pharmacotherapy for acromegaly, may still experience acromegaly…”
Get full text

Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice by Aliyu, S. H, Marriott, R. K, Curran, M. D, Parmar, S, Bentley, N, Brown, N. M, Brazier, J. S, Ludlam, H

“…1 Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Cambridge, UK 2 Anaerobe Reference Laboratory,…”
Get full text

Patients with Acromegaly Presenting with Colon Cancer: A Case Series by Gordon, Murray B., Ludlam, William H., Nakhle, Samer

“…Introduction. Frequent colonoscopy screenings are critical for early diagnosis of colon cancer in patients with acromegaly. Case Presentations. We performed a…”
Get full text

Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK? by Ludlam, H.A, Enoch, D.A

“…Abstract Macrolide monotherapy is currently recommended as first-line treatment of mild-to-moderate community-acquired pneumonia (CAP) in…”
Get full text

Incidence and prevalence of acromegaly in a large US health plan database by Burton, Tanya, Le Nestour, Elisabeth, Neary, Maureen, Ludlam, William H.

Get full text

Incidence and prevalence of acromegaly in a large US health plan database by Burton, Tanya, Le Nestour, Elisabeth, Neary, Maureen, Ludlam, William H.

“…Purpose Incidence and prevalence estimates of acromegaly in the United States (US) are limited. Most existing reports are based on European data sources. The…”
Get full text

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide by Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo

“…Abstract Purpose The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy and safety of oral octreotide capsules (OOCs) in patients with acromegaly…”
Get full text

Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults by COOK, D. M, LUDLAM, W. H, COOK, M. B

“…We prospectively studied two groups of GH-deficient patients during GH therapy based upon exposure of the liver to elevated (oral estrogen) or not elevated…”
Get full text

Non-fermentative Gram-negative bacteria by Enoch, D.A, Birkett, C.I, Ludlam, H.A

“…Abstract Over the past decade, non-fermenting Gram-negative bacteria have emerged as important opportunistic pathogens in the increasing population of patients…”
Get full text

The Acetyltransferase Activity of CBP Is Required for wingless Activation and H4 Acetylation in Drosophila melanogaster by Ludlam, William H., Taylor, Matthew H., Tanner, Kirk G., Denu, John M., Goodman, Richard H., Smolik, Sarah M.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Durable biochemical response and safety with oral octreotide capsules in acromegaly by Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Jensterle, Mojca, Manning, Patrick J, Elenkova, Atanaska, Molitch, Mark E, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke R, Giustina, Andrea, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo

“…Objective The objective of this study is to report results from the open-label extension (OLE) of the OPTIMAL trial of oral octreotide capsules (OOC) in adults…”
Get full text

Cyclic Cushing syndrome: definitions and treatment implications by Velez, Dennis A, Mayberg, Marc R, Ludlam, William H

“…Endogenous Cushing syndrome (CS) results from hypercortisolemia caused by excess adrenocorticotropic hormone production in a pituitary adenoma or ectopic…”
Get full text

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial by Fleseriu, Maria, Dreval, Alexander, Bondar, Irina, Vagapova, Gulnar, Macut, Djuro, Pokramovich, Yulia G, Molitch, Mark E, Leonova, Nina, Raverot, Gerald, Grineva, Elena, Poteshkin, Yury E, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Gordon, Murray B, Biermasz, Nienke R, Melmed, Shlomo, Strasburger, Christian J

“…Despite biochemically responding to injectable somatostatin receptor ligands (iSRLs), many patients with acromegaly experience treatment burdens. We aimed to…”
Get full text

Comfort with having sexual orientation recorded on official databases among a community and online sample of gay and bisexual men in Aotearoa New Zealand by Ludlam, A H, Petousis-Harris, H, Arroll, B, Saxton, P J W

“…Introduction Sexual orientation minorities have worse health outcomes than the heterosexual majority. In 2023, Aotearoa New Zealand (NZ) added sexual and…”
Get full text

Evidence from a UK teaching hospital that MRSA is primarily transmitted by the hands of healthcare workers by Ludlam, H.A, Swayne, R.L, Kearns, A.M, Brown, D.F.J, Howard, J.C, Gunning, K, Burnstein, R, Nicholl, C.G, Brown, N.M

Get full text